Spots Global Cancer Trial Database for bowel dysfunction
Every month we try and update this database with for bowel dysfunction cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Incidence of The Bowel, Bladder, and Sexual Dysfunction Following Surgery for Colorectal Malignancy | NCT04134104 | Bowel Dysfuncti... Bladder Dysfunc... Sexual Dysfunct... Colorectal Surg... | Surgery for Col... | 18 Years - 75 Years | National Academy of Medical Sciences, Nepal | |
| Translation of the International Consensus Definition of LARS Into a Bowl Dysfunction Severity Scoring Tool (New LARS Score) | NCT05605600 | Low Anterior Re... | 18 Years - | Cardiff and Vale University Health Board | ||
| Long - Term Low Anterior Resection Syndrome | NCT03920202 | Bowel; Function... | 18 Years - | National Cancer Institute, Lithuania | ||
| Physical Activity in Rectal Cancer Survivors | NCT06435975 | Rectal Cancer Rectosigmoid Ca... | Physical Activi... Survey Telehealth Life... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Feasibility Bowel Dysfunction Program After Low Anterior Resection | NCT04733794 | Rectal Cancer Low Anterior Re... | Stoma reversal | 18 Years - 80 Years | Fox Chase Cancer Center | |
| Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain | NCT00241722 | Bowel Dysfuncti... Constipation | Alvimopan Placebo | 18 Years - | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Incidence of The Bowel, Bladder, and Sexual Dysfunction Following Surgery for Colorectal Malignancy | NCT04134104 | Bowel Dysfuncti... Bladder Dysfunc... Sexual Dysfunct... Colorectal Surg... | Surgery for Col... | 18 Years - 75 Years | National Academy of Medical Sciences, Nepal | |
| Physical Activity in Rectal Cancer Survivors | NCT06435975 | Rectal Cancer Rectosigmoid Ca... | Physical Activi... Survey Telehealth Life... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| The OPERa Study: Evaluating QoL After Rectal Cancer Surgery | NCT04893876 | Rectal Cancer Quality of Life Bowel Dysfuncti... Sexual Dysfunct... Urinary Dysfunc... Emotional Distr... Surgery | 18 Years - | Jewish General Hospital | ||
| Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain | NCT00259922 | Bowel Dysfuncti... Constipation | Placebo Alvimopan Alviompan | 18 Years - | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Incidence of The Bowel, Bladder, and Sexual Dysfunction Following Surgery for Colorectal Malignancy | NCT04134104 | Bowel Dysfuncti... Bladder Dysfunc... Sexual Dysfunct... Colorectal Surg... | Surgery for Col... | 18 Years - 75 Years | National Academy of Medical Sciences, Nepal | |
| Development and Validation of The Post-RT LARS Prediction Model (PORTLARS) | NCT05129215 | Low Anterior Re... Radiotherapy Rectal Cancer | Questionnaire | - | Sixth Affiliated Hospital, Sun Yat-sen University | |
| Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain | NCT00241722 | Bowel Dysfuncti... Constipation | Alvimopan Placebo | 18 Years - | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Incidence of The Bowel, Bladder, and Sexual Dysfunction Following Surgery for Colorectal Malignancy | NCT04134104 | Bowel Dysfuncti... Bladder Dysfunc... Sexual Dysfunct... Colorectal Surg... | Surgery for Col... | 18 Years - 75 Years | National Academy of Medical Sciences, Nepal | |
| Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain | NCT00259922 | Bowel Dysfuncti... Constipation | Placebo Alvimopan Alviompan | 18 Years - | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain | NCT00256932 | Bowel Dysfuncti... Constipation | alvimopan Placebo | 18 Years - | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication | NCT00101998 | Constipation Bowel Dysfuncti... | alvimopan placebo | 18 Years - | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Physical Activity in Rectal Cancer Survivors | NCT06435975 | Rectal Cancer Rectosigmoid Ca... | Physical Activi... Survey Telehealth Life... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects | NCT00135577 | Cancer Bowel Dysfuncti... | alvimopan placebo | 18 Years - | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| A Prospective Multi-Center Research on Bowel Dysfunction After Sphincter Preservative Surgery | NCT03009747 | Bowel Dysfuncti... Rectal Cancer | 18 Years - | Peking University People's Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
